Conference Review: 17[sup]th[/sup] Confocal Raman Imaging Symposium

Ulm, Germany  October 7, 2021 This year’s Confocal Raman Imaging Symposium, held online, achieved a new level of engagement with a record number of participants from around the world. Over 500 registrants signed up to view and discuss a field of 55 posters grouped under the topics: Advanced Materials Analysis; Environmental and Geo Science; and... Read more

Olympus DP23M Monochrome Microscope Camera Simplifies Standard Fluorescence Imaging and Expression Checks

Premium image quality in a cost-effective camera WALTHAM, Mass., October 6, 2021—The newest Olympus DP series microscope camera—the DP23M monochrome camera—continues the series’ reputation for delivering high-quality images. With advanced features found on high-end microscope cameras, the DP23M monochrome camera provides premium fluorescence images at a reasonable cost. Fast, Efficient Fluorescence Protein Expression Checks The camera’s... Read more

PerkinElmer’s Horizon Discovery CHOSOURCE™ Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions

Existing CHO platform, featuring low cost and no royalty or license tie-ins, expands with new cell line to help develop biotherapeutics with increased potency and longevity and decreased side effects WALTHAM, Mass.– October 6, 2021, PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ platform is... Read more

EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 5, 2021– EUROIMMUN, a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S. Food and Drug Administration has provided Emergency Use Authorization (EUA) for its Anti-SARS-CoV-2 S1 CurveTM ELISA (IgG). This assay allows... Read more

Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance

Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance CARLSBAD, Calif., Oct. 5, 2021 /PRNewswire/ — Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. The effort has helped identify asymptomatic carriers on college campuses to monitor regional spread among communities... Read more

New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies

New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies Gibco CTS NK-Xpander Medium* enables large-scale growth of functional cells for cell therapy manufacturing CARLSBAD, Calif., Oct. 5, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the launch of Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, a GMP-manufactured cell culture medium... Read more

Pep Guardiola, Xylem Partner to Address Water Scarcity, Affordability

Legendary Football Coach Joins Forces with Water Technology Leader to Advance Water Sustainability RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 5, 2021– Global water technology company, Xylem (NYSE:XYL), and Manchester City Football Club manager, Pep Guardiola, today announced they are joining forces to promote public engagement on the world’s water challenges. The partners will campaign for awareness and... Read more

Roche to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis optica spectrum disorder at ECTRIMS 2021

OCREVUS (ocrelizumab) data to show sustained reduction in disability progression through 8 years for primary progressive multiple sclerosis (PPMS) and 7.5 years for relapsing MS (RMS) Long-term safety analysis of all clinical trials will reinforce the consistently favourable benefit-risk profile of OCREVUS ENSPRYNG (satralizumab) data to show efficacy and safety sustained over four years of... Read more

PerkinElmer Introduces Next Generation Cell Image Analysis and Management Software Platform to Help Streamline Drug Discovery Decision Making

Signals Image Artist helps scientists process and analyze 3D cell imaging, phenotypic and cell painting data in hours vs. days or weeks October 4, 2021 WHAT: PerkinElmer, Inc ., a global leader committed to innovating for a healthier world, today announced the launch of Signals Image Artist™ software, a next generation image analysis and management... Read more